MedGenome | About Us

MedGenome is a genomics and clinical data driven diagnostics and drug discovery research company founded in 2013.

We are the market leader in genetic diagnostics in India and offer comprehensive diagnostic solutions to researchers, doctors & hospitals. We have expertise in simultaneous genome sequencing and clinical data analysis to identify genetic mutations across several disease areas.

We operate the largest College of American Pathologists (CAP) accredited Next Generation Sequencing(NGS) lab in South East Asia housing cutting-edge genome sequencing platforms such as Illumina’s NovaSeq, HiSeq X, HiSeq 4000 and2500, MiSeq, etc.

OUR FOOTPRINT

covers the whole of India and parts of South Asia covering 218 serviceable locations

with over

1600

hospitals

and

more than

8000

clinicians leveraging

our services

We currently offer

more than

1000

genetic testing

across several disease categories such as paediatrics, neurology, oncology, hematology, endocrinology, nephrology, ophthalmology, etc.

Our Expertise

We have a team of molecular biologists, geneticists, data scientists and bioinformaticians who drive our genomics research. We have successfully built research pipelines addressing immune oncology, biomarker discovery, companion diagnostics and population-based genomic studies that tap the rich Indian diverse genotype.

We are the founding member of

GENOMEASIA 100K

an initiative to sequence

200,000+ Genomes

in Asia.

We have worked extensively on building clinical databases of

more than

1 Million

patients through collaborations.

We have a repository of clinical, phenotypic and genomics data for

more than

170,000

patients

to provide insights into complex diseases at the genetic and molecular level.

We have access to data that provides insights into genetic diversity of Indian population for

more than

4,500

population groups.

Innovation

Innovation is a core belief and many of our tests have been developed in-ouse including our comprehensive gene panels. We believe in continuous innovation to help reduce the cost of genetic tests and empower clinicians with actionable clinical insights to provide better outcomes. Our liquid biopsy test OncoTrack for monitoring cancer treatment is the only NGS-based ctDNA test available in India.

We hold several IPs that include Clinical Exome, TB testing, Liquid Biopsy, Tumour Mutation Burden, and many such tests developed for various diseases. We have also launched India centric Carrier Screening Test for couples planning a baby. In the Rare Disease segment, we offer Whole Exome, Clinical Exome and TrioExome sequencing test for identifying gene mutations that cause rare diseases.

MedGenome has entered strategic partnerships to provide best in class tests like Non-Invasive Prenatal Test(NIPT), Infectious Diseases and several other companion diagnostics partnerships with leading pharmaceutical companies.

Accreditations

As a firm believer in quality, MedGenome adheres to the highest international standards when it comes to our services and have obtained the prestigious CAP accreditation for our main lab in Bangalore.